Your SlideShare is downloading. ×
0
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Smedds seminaaar final
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Smedds seminaaar final

1,716

Published on

Published in: Health & Medicine
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,716
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
115
Comments
0
Likes
2
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  1. Self micro emulsifieddrug delivery system Presented by T.SHIVAKUMAR KOTTAM INSTITUTE OF PHARMACY
  2. WHAT IS SMEDDSSMEEDS is mixture of oils, surfactants, and cosurfactants, which are emulsified in aqueous media under conditions of gentle agitation of digestive motility that would be encountered in the gastro intestinal (GI) tract.
  3. AIMMost of the new drug candidates in development today are sparingly soluble and associated with poor bioavailabilityThe main purpose is to prepare SMEDDS for oral bioavailability enhancement of a poorly water soluble drug
  4. Bio pharmaceutical classificationsystem
  5. according to bio pharmaceutical classification system(BCS) the classII drugs have poor solubility and high permeability , thus the rate limiting process of absorption is the drug dissolution step. Formulation plays the major role in improving the rate and extent of absorption of such drugs from GI tract.
  6. Present studyIn the present study, an attempt was made to enhance the solubility and in vitro dissolution of candesartan cilexetil byformulating it as SMEDDS for filling into hard gelatin capsules.
  7. Drug profileCandesartan Cilexetil a prodrug is hydrolyzed to candesartan during absorption from the gastrointestinal tract., practically insoluble in water.Category: Antihypertensive AgentsSubcategory: Angiotensin II Receptor Antagonist
  8. Structure
  9. Materials Drug- Candesartan cilexetile-Oil -Miglyol 812Surfactants- Cremophor EL &Tween 80Cosurfactant -Labrasol
  10.  The quantity of each content will be taken according to the pseudo ternary phase diagramThis diagram is very essential in manipulation of ingredients in the formulation of SMEDDS
  11. CONSTRUCTION OF PSUEDO TERNARY PHASE DIAGRAMS: The pseudoternary phase diagrams of oil, surfactant– cosurfactant, and water were developed to optimize the formulation using a water titration method. The mixtures of oil and surfactant–cosurfactant ratios were diluted with water in a dropwise addition. Phase diagrams were constructed in the presence of drug to obtain the optimum concentrations of oil, surfactant, and cosurfactant. SMEDDS form fine oil–water emulsions upon addition to an aqueous media undergentle agitation.
  12. Pseudo ternary phase diagramThe gray area indicates the microemulsion region
  13. formulation Four self-microemulsifying formulations were prepared using mixtures of oils, surfactants, and cosurfactants in various proportions. The self-microemulsification properties, droplet size, and zeta potential of these formulations were studied upon dilution with water. The optimized liquid SMEDDS formulation was converted into free flowing powder by adsorbing onto a solid carrier for encapsulation.
  14. images of pure drug substance (left), solid SMEDDS(right; magnification
  15. Dissolution studiesThe dissolution characteristics of solid intermediates of SMEDDS filled into hard gelatin capsules was investigated and compared with liquid formulation and commercial formulation to ascertain the impact on self-emulsifying properties following conversion.
  16. ResultsThe results indicated that solid intermediates showed comparable rate and extent of drug dissolution in a discriminating dissolution medium as liquid SMEDDS indicating that the self-emulsifying properties of SMEDDS were unaffected following conversion. Also, the rate and extent of drug dissolution for solid intermediates was significantly higher than commercial tablet formulation. The results from this study demonstrate the potential use of SMEDDS as a means of improving solubility, dissolution, and concomitantly the bioavailability. 
  17. studies
  18. Advantages Protection of sensitive drug substances.The emulsion droplets will deliver the drug to GI mucosa in dissolved state readily accessible for absorptionWhen a polymer is incorporated in terms of SMEDDS it gives prolonged release of medicamentThey are comprised of aqueous and oily components and therfore can accommodate both hydrophilic aswell as lipophylic drugs
  19. DisadvantagesChemical instabilitiesIrritates GITPrecipitation of the lipophilic drugsPhysical and chemical changes in crystalline solid in Cryogenic grinding
  20. CONCLUSION A SMEDDS formulation of a poorly water-solubledrug, candesartan cilexetil was formulated for directfilling into hardgelatin capsules for oraladministrationshowed faster rate of drug release thanthe marketed product in a discriminating dissolution media. The results fromthis studydemonstrate the utility of SMEDDS to enhancesolubility anddissolution of sparingly soluble compounds likecandesartanwhich may result in improved therapeutic performance
  21. REFERENCES 1. Robinson JR. Introduction: semi-solid formulations for oral drug delivery. Bull Tech Gattefosse. 1996;89:11–3 2. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci. 1993;82:979–87. 3. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–72. 4. Pouton CW. Formulation of self-emulsifying drug delivery systems.
  22. Thank you….

×